InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

- Current share price for PIQ : $0.145

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Proposed issue of securities - PIQ 23 Jan 2024 9:07AM $0.910 $0.145 fallen by 84.07%
$24 December 2023 Quarterly Activities Report and Appendix 4C 23 Jan 2024 8:57AM $0.910 $0.145 fallen by 84.07%
$24 Notification of cessation of securities - PIQ 5 Jan 2024 4:40PM $0.850 $0.145 fallen by 82.94%
$24 PromarkerD licence with Omics Global extended to Chile 20 Dec 2023 9:12AM $0.790 $0.145 fallen by 81.65%
$24 Results of Meeting 23 Nov 2023 2:44PM $0.940 $0.145 fallen by 84.57%
$24 AGM Chairman's Address and Investor Presentation 23 Nov 2023 12:22PM $0.950 $0.145 fallen by 84.74%
$24 US Medicare confirms reimbursement price for PromarkerD 22 Nov 2023 9:13AM $0.910 $0.145 fallen by 84.07%
$24 Proteomics presents at Bell Potter Healthcare Conference 13 Nov 2023 9:13AM $0.920 $0.145 fallen by 84.24%
$24 Proteomics receives $1.85 million in R&D tax incentive 9 Nov 2023 9:19AM $0.890 $0.145 fallen by 83.71%
$24 Update on presentation to the ASN Conference 3 Nov 2023 9:23AM $0.890 $0.145 fallen by 83.71%
$24 Investor Presentation 30 Oct 2023 9:30AM $0.900 $0.145 fallen by 83.89%
$24 September 2023 Quarterly Activities Report and Appendix 4C 26 Oct 2023 9:10AM $0.865 $0.145 fallen by 83.24%
$24 Notification regarding unquoted securities - PIQ 24 Oct 2023 12:09PM $0.905 $0.145 fallen by 83.98%
$24 Issue of Equity Incentives to Employees 24 Oct 2023 12:08PM $0.905 $0.145 fallen by 83.98%
$24 Notice of Annual General Meeting/Proxy Form 23 Oct 2023 1:01PM $0.905 $0.145 fallen by 83.98%
$24 Notification of cessation of securities - PIQ 12 Oct 2023 11:57AM $0.960 $0.145 fallen by 84.90%
$24 Proteomics International Webinar and Q&A 29 Sep 2023 3:04PM $1.070 $0.145 fallen by 86.45%
$24 Reinstatement to Quotation 29 Sep 2023 9:19AM $0.900 $0.145 fallen by 83.89%
$24 PromarkerD US reimbursement price & Aus regulatory decision 29 Sep 2023 9:19AM $0.900 $0.145 fallen by 83.89%
$24 Request for extension of voluntary suspension 25 Sep 2023 9:29AM $0.900 $0.145 fallen by 83.89%
$24 Request for extension of voluntary suspension 20 Sep 2023 9:20AM $0.900 $0.145 fallen by 83.89%
$24 Suspension from Quotation 18 Sep 2023 9:42AM $0.900 $0.145 fallen by 83.89%
$24 Trading Halt 14 Sep 2023 9:49AM $0.900 $0.145 fallen by 83.89%
$24 New oesophageal cancer test presented at global conference 8 Sep 2023 8:24AM $0.870 $0.145 fallen by 83.33%
$24 OxiDx platform technology secures patent in Japan 4 Sep 2023 8:12AM $0.890 $0.145 fallen by 83.71%

176 - 200 of 689 results

Page 8 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.